Topics:
- Overview of China PV framework
- Updates on China's GVP policies
- China's GVP requirements
- Best practices for compliance with China's GVP requirements and authority inspection key points
- Tips and pitfalls
- Q&A session
The field of pharmacovigilance in China is characterized by its dynamic and fast-changing nature. As the country becomes increasingly important for pharmaceutical companies, it is crucial to stay informed about the latest regulatory developments to ensure compliance and safety. This essential pharmacovigilance session is designed to guide participants through the intricacies of compliance in China, providing valuable insights into Good Pharmacovigilance Practices (GVP) and post-market pharmacovigilance operations.
